(ANSA) - WASHINGTON, APRIL 13 - Johnson & Johnson has announced that it will delay deliveries of its vaccines to Europe.
"We are aware of the extremely rare" problems experienced by "a small number of people who have received our vaccine. The CDC and Fd are reviewing data from six cases in the United States on over 6.8 million doses administered. As a precaution, the CDC and the FDA have recommended a break in the use of our vaccine, "Johnson & Johnson said in a statement. "We are reviewing these cases with the European authorities and have proactively decided to delay deliveries to Europe," notes Johnson & Johnson. (HANDLE).